Search research articles
Contact Us
Filters
Showing results (781-790 of 849) with videos related to
Page
of 85
Sort By:
Gastroenterology
|
October 15, 2014
Daclatasvir plus peginterferon and ribavirin is noninferior to peginterferon and ribavirin alone, and reduces the duration of treatment for HCV genotype 2 or 3 infection
Gregory J Dore, Eric Lawitz, Christophe Hézode, et al.
Scientific Reports
|
July 12, 2018
A Data Mining-based Prognostic Algorithm for NAFLD-related Hepatoma Patients: A Nationwide Study by the Japan Study Group of NAFLD
Takumi Kawaguchi, Katsutoshi Tokushige, Hideyuki Hyogo, et al.
Indian Journal of Critical Care Medicine : Peer-Reviewed, Official Publication of Indian Society of Critical Care Medicine
|
September 14, 2019
Indian Antimicrobial Prescription Guidelines in Critically Ill Immunocompromised Patients
Atul P Kulkarni, Manju Sengar, Girish Chinnaswamy, et al.
Journal of Viral Hepatitis
|
May 18, 2026
Impact of Fatigue on Patient-Reported Outcomes and Work Productivity in Chronic Hepatitis B and C: Insights From a Multinational Registry Study
Yusuf Yilmaz, Ming-Lung Yu, Khalid Alswat, et al.
European Heart Journal
|
October 12, 2017
A common missense variant of LILRB5 is associated with statin intolerance and myalgia
Moneeza K Siddiqui, Cyrielle Maroteau, Abirami Veluchamy, et al.
Cellular and Molecular Life Sciences : CMLS
|
March 25, 2022
Fibrotic activity quantified in serum by measurements of type III collagen pro-peptides can be used for prognosis across different solid tumor types
Nicholas Willumsen, Christina Jensen, George Green, et al.
Plos Medicine
|
September 21, 2011
IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study
Vijayaprakash Suppiah, Silvana Gaudieri, Nicola J Armstrong, et al.
Hepatology (Baltimore, Md.)
|
December 10, 2017
Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Zobair M Younossi, Rohit Loomba, Mary E Rinella, et al.
Nature Communications
|
September 16, 2016
MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C
Khaled Thabet, Anastasia Asimakopoulos, Maryam Shojaei, et al.
The Journal of Pathology
|
February 15, 2021
Dual proteotoxic stress accelerates liver injury via activation of p62-Nrf2
Deniz Kuscuoglu, Lisa Bewersdorf, Kathrin Wenzel, et al.
Page
of 85
Search research articles
Search
Showing results (781-790 of 849) with videos related to
Sort By:
Page
of 85
Gastroenterology
|
October 15, 2014
Daclatasvir plus peginterferon and ribavirin is noninferior to peginterferon and ribavirin alone, and reduces the duration of treatment for HCV genotype 2 or 3 infection
Gregory J Dore, Eric Lawitz, Christophe Hézode, et al.
Scientific Reports
|
July 12, 2018
A Data Mining-based Prognostic Algorithm for NAFLD-related Hepatoma Patients: A Nationwide Study by the Japan Study Group of NAFLD
Takumi Kawaguchi, Katsutoshi Tokushige, Hideyuki Hyogo, et al.
Indian Journal of Critical Care Medicine : Peer-Reviewed, Official Publication of Indian Society of Critical Care Medicine
|
September 14, 2019
Indian Antimicrobial Prescription Guidelines in Critically Ill Immunocompromised Patients
Atul P Kulkarni, Manju Sengar, Girish Chinnaswamy, et al.
Journal of Viral Hepatitis
|
May 18, 2026
Impact of Fatigue on Patient-Reported Outcomes and Work Productivity in Chronic Hepatitis B and C: Insights From a Multinational Registry Study
Yusuf Yilmaz, Ming-Lung Yu, Khalid Alswat, et al.
European Heart Journal
|
October 12, 2017
A common missense variant of LILRB5 is associated with statin intolerance and myalgia
Moneeza K Siddiqui, Cyrielle Maroteau, Abirami Veluchamy, et al.
Cellular and Molecular Life Sciences : CMLS
|
March 25, 2022
Fibrotic activity quantified in serum by measurements of type III collagen pro-peptides can be used for prognosis across different solid tumor types
Nicholas Willumsen, Christina Jensen, George Green, et al.
Plos Medicine
|
September 21, 2011
IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study
Vijayaprakash Suppiah, Silvana Gaudieri, Nicola J Armstrong, et al.
Hepatology (Baltimore, Md.)
|
December 10, 2017
Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Zobair M Younossi, Rohit Loomba, Mary E Rinella, et al.
Nature Communications
|
September 16, 2016
MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C
Khaled Thabet, Anastasia Asimakopoulos, Maryam Shojaei, et al.
The Journal of Pathology
|
February 15, 2021
Dual proteotoxic stress accelerates liver injury via activation of p62-Nrf2
Deniz Kuscuoglu, Lisa Bewersdorf, Kathrin Wenzel, et al.
Page
of 85